Company / EPS (Diluted)
HARROW, INC. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.75
FY2025
5-year range
-$0.75 / -$0.13
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#77 of 204
Health Care
What the data says
At $-0.75, HARROW, INC.'s eps (diluted) ranks #77 of 204 in the Health Care sector. Declined from $-0.51 to $-0.75 over the past 2 years.
Based on SEC 10-K filings.
-0.75 in FY2025.
Declined from $-0.51 to $-0.75 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#77 of 204 in Health CareTop 38% of 204This company -$0.75 Sector average -$0.98
▼
+23.4% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 0.0% year-over-year.
- Ranks #77 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2019.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.75 | +0.0% |
| FY2024 | -$0.75 | -47.1% |
| FY2023 | -$0.51 | - |
| FY2022 | - | - |
| FY2021 | -$0.13 | -1400.0% |
| FY2020 | $0.01 | -98.4% |
| FY2019 | $0.61 | +201.7% |
| FY2018 | -$0.60 | +60.0% |
| FY2017 | -$1.50 | +9.6% |
| FY2016 | -$1.66 | -49.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026